Client Alert

FTC Finalizes Long-Awaited HSR Overhaul

The long-awaited new HSR rules and Form have been released. They go into effect in approximately 90 days (mid-January), unless blocked by a federal judge. Companies engaging in M&A now face increased burdens compared to the previous rules.

Read More

Practices
Type
People
Most recent

7 results

July 16, 2024

The Chambers Merger Control 2024 Guide

Partners Lisl Dunlop and Bradley Justus and associates Josh Jowdy and Megan Walden contributed the USA "Trends and Developments" and "Law and Practice" chapters to the Chambers and Partners Merger Control 2024 Guide.

Byline Articles

Antitrust

July 10, 2024

Axinn Advises Thermo Fisher Scientific in Securing Global Merger-Control Clearances for its Acquisition of Olink Holding

Axinn is pleased to represent Thermo Fisher Scientific (NYSE: TMO), a global life sciences leader, in helping obtain unconditional regulatory clearance worldwide in its $3.1 billion acquisition of Olink Holding (Nasdaq: OLK), the Swedish provider of next-generation proteomics solutions.

Deals & Cases

Antitrust

February 16, 2024

Axinn Secures Antitrust Clearance for Ball Corporation’s $5.6B Sale to BAE Systems

Axinn congratulates its client Ball Corporation, the world's leading producer of sustainable aluminum packaging for global beverage and household brands, which today announced the successful completion of its $5.6B sale of its aerospace business to BAE Systems. As lead antitrust counsel to Ball, Axinn played a pivotal role in securing antitrust clearance less than six months after Ball and BAE announced the transaction.

Deals & Cases

Antitrust

August 17, 2023

Axinn Advises Ball Corporation in its $5.6 Billion Sale of its Aerospace Division to BAE Systems

Axinn is antitrust counsel to Ball Corporation in its $5.6 billion sale of its aerospace division to BAE Systems. Led by partner Nick Gaglio, the Axinn team includes partner Jimmy Attridge and lead associate Danielle Irvine, with assistance from associates Megan Walden, and Quinten Stewart*.

News

Antitrust

August 11, 2023

USA: Law and Practice & Trends and Developments

Axinn partners Lisl Dunlop and Bradley Justus, along with associates Josh Jowdy and Megan Walden, co-authored the "USA" chapter of the Chambers Global Practice Guides – Merger Control 2023. This chapter explores the state of merger control in the United States, including legislation and enforcing authorities; third-party rights; confidentiality and cross-border co-operation; appeals and judicial review; and recent trends and developments. 

Publications

Antitrust

August 8, 2022

USA: Law and Practice

Axinn partners Bradley Justus and Lisl Dunlop, along with associate Megan Walden, co-authored the "USA: Law and Practice” chapter of the Chambers Global Practice Guides – Merger Control 2022. This chapter explores the state of merger control in the United States, including legislation and enforcing authorities; third-party rights; confidentiality and cross-border co-operation; appeals and judicial review; and current enforcement priorities.

Publications

Antitrust

January 5, 2022

Axinn Advised Thermo Fisher on $1.85B Acquisition of PeproTech, Inc.

Axinn represented Thermo Fisher Scientific Inc., the world leader in serving science, in its approximately $1.85 billion acquisition of PeproTech, Inc., a leading developer and manufacturer of recombinant proteins. The deal closed on December 30, 2021. The Axinn antitrust team included partners John Harkrider and Mark Alexander, who were assisted by Craig Minerva, Tasneem Chowdhury, Megan Walden, and Kyle Sherwood.

News

Antitrust

Events

See all events

© 2024 Axinn, Veltrop & Harkrider LLP. All Rights Reserved

Practices

People

Practices

People

LinkedIn

Phone

DC:(+1) 202.912.4700

NY:(+1) 212.728.2200

CA:(+1) 415.490.2000

CT:(+1) 860.275.8100

Attorney Advertising
Legal Notices
Privacy Policy
© 2024 Axinn, Veltrop & Harkrider LLP

Back to top